Covid 19

Class 5 Dropout Gujarat BJP MLA Seen Filling Syringe With Remdesivir; Faces Flak

After filling the syringe, he is seen transferring it to a drip bottle which is to be administered to a Covid-19 patient. Defending his action, VD Jhalavadiya said he did not administer the dose to any patient but only transferred the remdesivir injection to the drip bottle.

Gujarat BJP MLA VD Jhalawadia on Sunday was spotted filling a syringe from Remdesivir vial at Sarthana Community Covid Center, run in collaboration with the Surat Municipal Corporation. The legislator, who is a class five dropout, was at the Center in Surat’s satellite town for a meeting with the medical staff.

After filling the syringe, he is seen transferring it to a drip bottle which is to be administered to a Covid-19 patient. Defending his action, VD Jhalavadiya said he did not administer the dose to any patient but only transferred the remdesivir injection to the drip bottle.

“I am doing voluntary work in Sarthana Community Hall for the last 40 days, and helping patients with Covid care. I have no intention of being a part of any controversy. I only filled the syringe with Remdesivir dose, and did not inject anyone. There were almost 10-15 doctors present with me. I have helped cure nearly 200 people and send them home in a healthy state,” Jhalawadia said.

Congress spokesperson Jairaj Singh, taking a jibe at Jhalawadia said that medical staff should learn from the legislator. He even recommended establishing MLA’s statue at hospitals.

Hitting back at Congress, the MLA said, “Congress has nothing better to do than create controversy and criticize good works done by others.”

Also Read: Congress “Toolkit” Case: Delhi Police Carries Out Search operation At Twitter India Offices

Gujarat had recently been facing shortage, black-marketing and counterfeiting of antiviral injection Remdesivir, which is used to treat Covid-19 patients. However, AIIMS director Dr Randeep Guleria, who was in Gujarat as part of a central team to take stock of the Covid-19 situation in July 2020, had said that “oxygen therapy, steroids in mild to moderate patients, anticoagulants and prone positioning would save more lives than Tocilizumab or Remdesivir”.

According to a report in Indian Express, the Gujarat government in September 2020 increased the procurement of the drug when a shortage was reported. By mid-April when the demand exceeded the available supply and stock, the state government blamed the public for “panic buying and hoarding” and also blamed doctors for “indiscriminate” prescription of the drug.

A study from the World Health Organization (WHO) had, however, found Remdesivir has little to no effect on Covid-19 patients’ chances of survival.

India reported 2,22,315 cases and 4454 deaths in the last 24 hours.

Dear Readers,
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.

Related posts